GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » YoY EBITDA Growth

Lombard Medical Technologies (LSE:LMT) YoY EBITDA Growth : 0.00% (As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Lombard Medical Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2012 was 0.00%.

Lombard Medical Technologies's EBITDA per Share for the six months ended in Dec. 2012 was £-0.40.

Lombard Medical Technologies YoY EBITDA Growth Historical Data

The historical data trend for Lombard Medical Technologies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies YoY EBITDA Growth Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.08 87.84 58.83 16.67 42.17

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lombard Medical Technologies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Lombard Medical Technologies's YoY EBITDA Growth for the fiscal year that ended in Dec. 2012 is calculated as:

YoY EBITDA Growth (A: Dec. 2012 )
=(EBITDA per Share (A: Dec. 2012 )-EBITDA per Share (A: Dec. 2011 ))/ | EBITDA per Share (A: Dec. 2011 ) |
=(-0.399--0.69)/ | -0.69 |
=42.17 %

Lombard Medical Technologies's YoY EBITDA Growth for the quarter that ended in Dec. 2012 is calculated as:

YoY EBITDA Growth (Q: Dec. 2012 )
=(EBITDA per Share (Q: Dec. 2012 )-EBITDA per Share (Q: Dec. 2011 )) / | EBITDA per Share (Q: Dec. 2011 ) |
=(-0.399--0.557)/ | -0.557 |
=28.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lombard Medical Technologies YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » YoY EBITDA Growth
Comparable Companies
XKLS:2127 HBIO XKRX:179290 UGHL ROCO:6612 ROCO:4150 XKRX:049180 HKSE:00876 OHEL:SILMA OSTO:ELOS B ISX:MARK IGAP XPAR:AMPLI ROCO:5312 BKK:TOG HKSE:01120 SSKN TSE:7775 ROCO:6499 OSTO:QLINEA
Traded in Other Exchanges
N/A
Address
Website
http://www.lombardmedical.com
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.